T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Procept Biorobotics
PRCT
$1.25B
| $76.2M | 0.01% |
1,322,439
+266,677
| +25% | +$15.1M |
|
627
Royal Gold
RGLD
$19.2B
| $75.8M | 0.01% |
426,213
+20,989
| +5% | +$3.72M |
|
628
Agios Pharmaceuticals
AGIO
$2.01B
| $75.6M | 0.01% |
2,274,249
-27,104
| -1% | -$822K |
|
629
Sprouts Farmers Market
SFM
$7.7B
| $75M | 0.01% |
455,530
+178,029
| +64% | +$29.1M |
|
630
Credo Technology Group
CRDO
$51.7B
| $74.6M | 0.01% |
806,103
-221,886
| -22% | -$12.9M |
|
631
DraftKings
DKNG
$12.5B
| $74.5M | 0.01% |
1,737,528
+389,353
| +29% | +$14M |
|
632
Universal Health Services
UHS
$10.1B
| $74M | 0.01% |
408,558
+324,550
| +386% | +$58.6M |
|
633
HDFC Bank
HDB
$120B
| $73.8M | 0.01% |
1,925,064
-152,344
| -7% | -$5.52M |
|
634
BrightSpring Health Services
BTSG
$12B
| $73.7M | 0.01% |
3,124,078
+603,858
| +24% | +$12.6M |
|
635
Sterling Infrastructure
STRL
$16.9B
| $73.7M | 0.01% |
319,331
+65,810
| +26% | +$11.5M |
|
636
HealthEquity
HQY
$8.73B
| $73.4M | 0.01% |
700,369
+61,024
| +10% | +$5.78M |
|
637
T. Rowe Price Growth Stock ETF
TGRW
$1.04B
| $73.3M | 0.01% |
1,745,001
| – | – |
|
638
iShares Core US Aggregate Bond ETF
AGG
$138B
| $73.2M | 0.01% |
738,330
+17,925
| +2% | +$1.76M |
|
639
Colliers International
CIGI
$5.27B
| $73.1M | 0.01% |
560,048
+71,317
| +15% | +$8.69M |
|
640
VeriSign
VRSN
$25.5B
| $72.6M | 0.01% |
251,290
+22,955
| +10% | +$6.22M |
|
641
Rocket Lab Corp
RKLB
$51.9B
| $72.5M | 0.01% |
2,027,505
+1,000,478
| +97% | +$24.5M |
|
642
Mirum Pharmaceuticals
MIRM
$6.02B
| $72.1M | 0.01% |
1,417,215
+2,078
| +0.1% | +$92.5K |
|
643
Petrobras
PBR
$115B
| $72M | 0.01% |
5,759,116
-2,329,600
| -29% | -$27.9M |
|
644
Loar Holdings
LOAR
$6.87B
| $70.6M | 0.01% |
818,922
+37,841
| +5% | +$3.28M |
|
645
Insulet
PODD
$10B
| $70.4M | 0.01% |
224,058
+17,801
| +9% | +$5.14M |
|
646
Ivanhoe Electric
IE
$1.67B
| $69.9M | 0.01% |
7,706,643
+875,023
| +13% | +$6.07M |
|
647
First Bancorp
FBP
$4.51B
| $69.2M | 0.01% |
3,321,377
+550,772
| +20% | +$10.8M |
|
648
Payoneer
PAYO
$2.42B
| $68.6M | 0.01% |
10,011,033
+1,040,738
| +12% | +$7.05M |
|
649
Merit Medical Systems
MMSI
$5.42B
| $68.5M | 0.01% |
732,344
-19,686
| -3% | -$1.87M |
|
|
MASI
650
DELISTED
Masimo
MASI
| $68.2M | 0.01% |
405,460
+122,823
| +43% | +$19.6M |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.